NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England

A Contract Award Notice
by NHS ENGLAND

Source: Contracts Finder
Type: Framework (Products)
Duration: 27 month
Value: £3B

Sector: HEALTH
Published: 25 Nov 2021
Delivery: 01 Jan 2022 to 31 Mar 2024
Deadline: 03 Sep 2021 13:00

Concepts

Location

Geochart for 1 buyers and 3 suppliers

1 buyer

NHS England London

3 suppliers

Bristol Myers Squibb Uxbridge
Bayer Reading
Daiichi Sankyo Uxbridge

Description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs). Period of Framework: 01/01/2022 - 31/03/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 39 months)

Award Detail

1	Bristol Myers Squibb (Uxbridge) Value: £3,185,000,000
2	Bayer (Reading) Value: £3,185,000,000
3	Daiichi Sankyo (Uxbridge) Value: £3,185,000,000